Osteopontin ablation attenuates progression of colitis in TNBS model

Digestive Diseases and Sciences

Volumn 57, Issue 6, 2012, Pages 1554-1561

  Oz, Helieh S ^a   Zhong, Jian ^a   De Villiers, Willem J S ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

IBD; Macrophages; Osteopontin; TNBS

Indexed keywords

GLYCOPROTEIN; MACROSIALIN; OSTEOPONTIN; SCAVENGER RECEPTOR; SERUM AMYLOID A; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CROHN DISEASE; DISEASE COURSE; FLOW CYTOMETRY; HISTOPATHOLOGY; INFLAMMATION; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; BIOPSY, NEEDLE; COLITIS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOPONTIN; RANDOM ALLOCATION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SERUM AMYLOID A PROTEIN; TRINITROBENZENESULFONIC ACID;

EID: 84864280417     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-2009-z     Document Type: Article

References (28)

1. Caillier S, Barcellos LF, Baranzini SE, et al. Multiple sclerosis genetics group. Osteopontin polymorphisms and disease course in multiple sclerosis. Genes Immun. 2003;4:312-315. (Pubitemid 39562131)
2. Sato T, Nakai T, Tamura N, et al. Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response. Gut. 2005;54:1254-1262. (Pubitemid 41192483)
3. Mishima R, Takeshima F, Sawai T, et al. High plasma osteopontin levels in patients with inflammatory bowel disease. J Clin Gastroenterol. 2007;41:123-125.
4. Oz HS, Ebersole JL. Application of prodrugs to inflammatory diseases of the gut. Molecules. 2008;13:452-474 (review).
5. Neuman MG. Immune dysfunction in inflammatory bowel disease. Transl Res. 2007;149:173-186. (Pubitemid 46442010)
6. Hume DA, Allan W, Hogan PG, Doe WF. Immunohistochemical characterization of macrophages in human liver and gastrointestinal tract: expression of CD4, HLA-DR, OKM1, and the mature macrophage marker 25F9 in normal and diseased tissue. J Leuko Biol. 1987;42:474-484.
7. Oshitani N, Campbell A, Kitano A, Kobayashi K, Jewell DP. In situ comparison of phenotypical and functional activity of infiltrating cells in ulcerative colitis mucosa. J Pathol. 1996;178:95-99. (Pubitemid 26052087)
8. Rugtveit J, Brandtzaeg P, Halstensen TS, Fausa O, Scott H. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut. 1994;35:669-674. (Pubitemid 24163796)
9. Grimm MC, Pullman WE, Bennett GM, Sullivan PJ, Pavli P, Doe WF. Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa. J Gastro Hepatol. 1995;10:387-395.
10. Patarca R, Wei FY, Singh P, Morasso MI, Cantor H. Dysregulated expression of the T cell cytokine Eta-1 in CD4-8-lym-phocytes during the development of murine autoimmune disease. J Exp Med. 1990;172:1177-1183. (Pubitemid 20343218)
11. Lampe MA, Patarca R, Iregui MV, Cantor H. Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease. J Immunol. 1991;147:2902-2906.
12. Yamamoto N, Sakai F, Kon S, et al. Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J Clinic Invest. 2003;112:181-188. (Pubitemid 38056354)
13. Masuda H, Takahashi Y, Asai S, Hemmi A, Takayama T. Osteopontin expression in ulcerative colitis is distinctly different from that in Crohn's disease and diverticulitis. J Gastro. 2005;40:409-413. (Pubitemid 40723931)
14. Oz HS, Chen T, Nagasawa H. Comparative efficacies of two cysteine prodrugs and a glutathione delivery agent in a colitis model. Transl Res. 2007;150:122-129. (Pubitemid 47081449)
15. Zhong J, Eckhardt ER, Oz HS, Bruemmer D, de Villiers W. Osteopontin deficiency protects mice from DSS-induced colitis. Inflam Bowel Dis. 2006;12:790-796. (Pubitemid 44253763)
16. Oz HS, Chen T, Ebersole JL. A model for chronic mucosal inflammation in IBD and periodontitis. Dig Dis Sci. 2010; 55:2194-2202.
17. Reinholt FP, Hultenby K, Oldberg A, Heinegard D. Osteopontin - a possible anchor of osteoclasts to bone. Proc Natl Acad Sci USA. 1990;87:4473-4475.
18. Giachelli CM, Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol. 2000;19: 615-622.
19. Ashkar S, Weber GF, Panoutsakopoulou V, et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science. 2000;287:860-864. (Pubitemid 30084330)
20. Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol. 1998; 152:353-358. (Pubitemid 28106380)
21. Heilmann K, Hoffmann U, Witte E, et al. Osteopontin as two-sided mediator of intestinal inflammation. J Cell Mol Med. 2009; 13:1162-1174.
22. Da Silva AP, Pollett A, Rittling SR, Denhardt DT, Sodek J, Zohar R. Exacerbated tissue destruction in DSS-induced acute colitis of OPN-null mice is associated with downregulation of TNF-alpha expression and non-programmed cell death. J Cell Physiol. 2006;208:629-639. (Pubitemid 44141888)
23. Grassl GA, Valdez Y, Bergstrom KS, Vallance BA, Finlay BB. Chronic enteric salmonella infection in mice leads to severe and persistent intestinal fibrosis. Gastroenterology. 2008;134:768-780.
24. Ardite E, Sans M, Panes J, Romero F, Pique JM, Fernandez-Checa J. Replenishment of glutathione levels improves mucosal function in experimental acute colitis. Lab Invest. 2000;80: 735-744. (Pubitemid 30340658)
25. Oz HS, Ebersole JL. A novel murine model for chronic inflammatory alveolar bone loss. J Periodontal Resh. 2010;45:94-99.
26. Grisham MB, Volkmer C, Tso P, Yamada T. Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species. Gastroenterology. 1991;101:540-547.
27. Rath HC, Schultz M, Freitag R, et al. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun. 2001;69:2277-2285. (Pubitemid 32241818)
28. 3 integrin ligands regulate increased smooth muscle growth in TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol. 2009;296:G1230-G1237.